Drug intelligence / Profile preview

oxytocin morpholino antisense

Development stage
Unknown
Lead developer
University of California, Davis
Modality
Antisense Oligonucleotides (ASOs) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Single-strand DNA → Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Modified DNA Oligonucleotides → Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intrathecal
01

Overview

Oxytocin morpholino antisense is an antisense morpholino oligonucleotide designed to selectively inhibit the translation of oxytocin (Oxt) mRNA. Developed primarily as a research tool by researchers at the University of California, Davis, this synthetic oligonucleotide blocks the synthesis of the neuropeptide oxytocin in specific brain regions, such as the paraventricular nucleus (PVN) and the bed nucleus of the stria terminalis (BNST). In preclinical animal models, particularly California mice (*Peromyscus californicus*), localized administration of this morpholino has been utilized to study the distinct roles of specific oxytocin-producing neuronal populations in modulating social behaviors, including social approach, social avoidance, and social vigilance under stress or unstressed conditions.

Other names
oxytocin antisense morpholinooxytocin antisense morpholino oligonucleotideoxytocin morpholinooxytocin morpholino antisenseoxytocin morpholino antisense oligonucleotide
02

Targets

Oxytocin receptor

Beyond the preview

Go deeper on oxytocin morpholino antisense.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oxytocin morpholino antisense.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call